IHS Chemical Week

Regions :: Western Europe

DSM Buys Stake in Antibody Firm

10:53 AM MDT | March 18, 2008 | Chemical Week Editorial Staff

DSM Venturing, the venture capital arm of DSM, says it has made an equity investment in biotech firm IQ Therapeutics (Groningen, the Netherlands), a developer of antibodies for vaccines. DSM says it holds a“significant minority share in the business,” although financial terms were not disclosed. IQ Therapeutics’ portfolio includes an anti-anthrax vaccine, a product with “great potential,” says Karen King, president, DSM...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa